Cargando…

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models

BACKGROUND: Despite tremendous progress in diagnosis and prediction of Alzheimer’s disease (AD), the absence of treatments implies the need for further research. In this study, we screened AD biomarkers by comparing expression profiles of AD and control tissue samples and used various models to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Cuihua, Su, Li, Pan, Mika, Chen, Liechun, Li, Hepeng, Zou, Chun, Xie, Jieqiong, Huang, Xiaohua, Lu, Mengru, Zou, Donghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978156/ https://www.ncbi.nlm.nih.gov/pubmed/36875704 http://dx.doi.org/10.3389/fnagi.2023.1079433

Ejemplares similares

REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
por: Luo, Jiefeng, et al.
Publicado: (2022)

Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
por: Zou, Chun, et al.
Publicado: (2022)

Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease
por: Liang, Lucong, et al.
Publicado: (2022)

Exploring Early Physical Examination Diagnostic Biomarkers for Alzheimer's Disease Based on Least Absolute Shrinkage and Selection Operator
por: Lin, Hua, et al.
Publicado: (2022)

Identification of Alzheimer’s Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing
por: Ma, Meigang, et al.
Publicado: (2022)

Analysis of transcription factor- and ncRNA-mediated potential pathogenic gene modules in Alzheimer’s disease
por: Zou, Cuihua, et al.
Publicado: (2019)

Microglia Mediate the Occurrence and Development of Alzheimer’s Disease Through Ligand-Receptor Axis Communication
por: Jian, Chongdong, et al.
Publicado: (2021)

Corrigendum: Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication
por: Jian, Chongdong, et al.
Publicado: (2021)

Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway
por: Wei, Lei, et al.
Publicado: (2023)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease
por: Li, Kunlin, et al.
Publicado: (2022)

Exploring the combined effects of sleep apnea and APOE-e4 on biomarkers of Alzheimer’s disease
por: Turner, Arlener D., et al.
Publicado: (2023)

Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset
por: Feng, Bing, et al.
Publicado: (2021)

Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease
por: Ghiam, Shokoofeh, et al.
Publicado: (2022)

Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer’s disease: a bibliometric analysis
por: Zou, Yutong, et al.
Publicado: (2023)

Corrigendum: Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis
por: Zou, Yutong, et al.
Publicado: (2023)

Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease
por: Chen, Danmei, et al.
Publicado: (2022)

Identification of an miRNA Regulatory Network and Candidate Markers for Ischemic Stroke Related to Diabetes
por: Zhou, Hui, et al.
Publicado: (2021)

Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis
por: Ye, Xian-wen, et al.
Publicado: (2023)

Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma
por: Wei, Lei, et al.
Publicado: (2022)

Identification of Candidate Genes Associated With Prognosis in Glioblastoma
por: Li, Rongjie, et al.
Publicado: (2022)

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Altered functional association and couplings: Effective diagnostic neuromarkers for Alzheimer’s disease
por: Zhao, Chongyi, et al.
Publicado: (2022)

Motoric cognitive risk syndrome as a predictor of incident disability: A 7 year follow-up study
por: Bai, Anying, et al.
Publicado: (2022)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease
por: Li, Lixia, et al.
Publicado: (2022)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Identification of miRNA–mRNA Pairs in the Alzheimer’s Disease Expression Profile and Explore the Effect of miR-26a-5p/PTGS2 on Amyloid-β Induced Neurotoxicity in Alzheimer’s Disease Cell Model
por: Xie, Tao, et al.
Publicado: (2022)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022)

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbcm68ql4tb09m9t6887desh79